The overexpression of MMP3 and its function as a prognostic factor have been reported in breast, cervical, renal, colorectal, gastric, lung, melanoma, pancreatic, and ovarian carcinomas [27,28,29,30]. This evidence concerns the gene MMP3 and ovarian carcinoma.